IBIO
Ibio Inc
NASDAQ · Biotechnology
$2.42
+0.27 (+12.56%)
Open$2.20
Previous Close$2.15
Day High$2.50
Day Low$2.20
52W High$13.90
52W Low$10.90
Volume—
Avg Volume423.7K
Market Cap54.42M
P/E Ratio16.02
EPS$0.78
SectorBiotechnology
Analyst Ratings
Strong Buy
10 analysts
Price Target
+485.1% upside
Current
$2.42
$2.42
Target
$14.16
$14.16
$9.87
$14.16 avg
$18.59
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 20.82M | 19.24M | 18.65M |
| Net Income | -2,950,674 | -3,136,016 | -2,526,921 |
| Profit Margin | -14.2% | -16.3% | -13.6% |
| EBITDA | -4,486,253 | -4,591,050 | -4,236,243 |
| Free Cash Flow | -3,503,805 | -2,958,449 | -2,128,422 |
| Rev Growth | +9.7% | -5.9% | +5.1% |
| Debt/Equity | 0.56 | 0.76 | 0.65 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |